Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Observational × Hydatidiform Mole × Clear all

Status

Recruiting 2 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 99 Breast Neoplasms 97 Lung Neoplasms 60 Colorectal Neoplasms 52 Prostatic Neoplasms 45 Carcinoma, Non-Small-Cell Lung 44 Carcinoma, Hepatocellular 44 Uterine Cervical Neoplasms 31 Disease 28 Pancreatic Neoplasms 27 Ovarian Neoplasms 25 Stomach Neoplasms 23 Rectal Neoplasms 22 Multiple Myeloma 22 Esophageal Neoplasms 19 Glioblastoma 18 Endometrial Neoplasms 18 Glioma 16 Colonic Neoplasms 16 Leukemia, Myeloid, Acute 15 Urinary Bladder Neoplasms 14 Recurrence 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Neoplasm Metastasis 14 Melanoma 14 Head and Neck Neoplasms 14 Cholangiocarcinoma 14 Lymphoma 13 Neoplasm, Residual 11 Leukemia, Lymphocytic, Chronic, B-Cell 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05637892 2022-12-08

A Cohort Study of Hydatidiform Mole

Women's Hospital School Of Medicine Zhejiang University

Not yet recruiting

Hydatidiform Mole

Data powered by HemOnc (CC BY 4.0) Colophon ⚡